Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lim

Showing results (431-440 of 468) with videos related to

Pageof 47
Sort By:
The Lancet. Oncology|December 7, 2017
Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' replyMichael Weller, Nicholas Butowski, David D Tran, et al.
The Lancet. Oncology|August 29, 2017
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trialMichael Weller, Nicholas Butowski, David D Tran, et al.
Journal of Neuro-Oncology|October 30, 2025
The relationship between extent of resection, tumor recurrence, and facial nerve outcomes in vestibular schwannoma surgery: a single-institution experience and systematic reviewSai Chandan Reddy, S Farzad Maroufi, James Feghali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2022
Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent GlioblastomaLakshmi Nayak, Nathan Standifer, Jorg Dietrich, et al.
Journal of Neurosurgery. Spine|April 24, 2026
Utility of direct wave intraoperative neuromonitoring for intramedullary spinal cord tumor resectionKelly Jiang, Abdel-Hameed Al-Mistarehi, Khaled J Zaitoun, et al.
Cancer Research|December 2, 2024
Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma ProgressionCaren Yu-Ju Wu, Yiyun Chen, Ya-Jui Lin, et al.
Neurosurgery|July 28, 2021
A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary GlioblastomaAdham M Khalafallah, Maureen Rakovec, Chetan Bettegowda, et al.
Neurosurgical Review|April 15, 2026
Temporal patterns of facial nerve palsy after microsurgical resection of vestibular schwannoma: immediate vs. delayed onset, management, and outcomesSai Chandan Reddy, S Farzad Maroufi, James Feghali, et al.
Journal of Neuro-Oncology|December 23, 2025
Predictors of postoperative gustatory disturbance and gustatory recovery following microsurgical resection of vestibular schwannomaSai Chandan Reddy, James Feghali, A Karim Ahmed, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
BRAF/MEK Inhibition Induces Cell State Transitions Boosting Immune Checkpoint Sensitivity in BRAFV600E -mutant GliomaYao Lulu Xing, Dena Panovska, Jong-Whi Park, et al.
Pageof 47

Showing results (431-440 of 468) with videos related to

Sort By:
Pageof 47
The Lancet. Oncology|December 7, 2017
Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' replyMichael Weller, Nicholas Butowski, David D Tran, et al.
The Lancet. Oncology|August 29, 2017
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trialMichael Weller, Nicholas Butowski, David D Tran, et al.
Journal of Neuro-Oncology|October 30, 2025
The relationship between extent of resection, tumor recurrence, and facial nerve outcomes in vestibular schwannoma surgery: a single-institution experience and systematic reviewSai Chandan Reddy, S Farzad Maroufi, James Feghali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2022
Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent GlioblastomaLakshmi Nayak, Nathan Standifer, Jorg Dietrich, et al.
Journal of Neurosurgery. Spine|April 24, 2026
Utility of direct wave intraoperative neuromonitoring for intramedullary spinal cord tumor resectionKelly Jiang, Abdel-Hameed Al-Mistarehi, Khaled J Zaitoun, et al.
Cancer Research|December 2, 2024
Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma ProgressionCaren Yu-Ju Wu, Yiyun Chen, Ya-Jui Lin, et al.
Neurosurgery|July 28, 2021
A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary GlioblastomaAdham M Khalafallah, Maureen Rakovec, Chetan Bettegowda, et al.
Neurosurgical Review|April 15, 2026
Temporal patterns of facial nerve palsy after microsurgical resection of vestibular schwannoma: immediate vs. delayed onset, management, and outcomesSai Chandan Reddy, S Farzad Maroufi, James Feghali, et al.
Journal of Neuro-Oncology|December 23, 2025
Predictors of postoperative gustatory disturbance and gustatory recovery following microsurgical resection of vestibular schwannomaSai Chandan Reddy, James Feghali, A Karim Ahmed, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
BRAF/MEK Inhibition Induces Cell State Transitions Boosting Immune Checkpoint Sensitivity in BRAFV600E -mutant GliomaYao Lulu Xing, Dena Panovska, Jong-Whi Park, et al.
Pageof 47